In 1987, Canadian medical researcher Dr. Victoria Hale developed an innovative pharmaceutical formulation system designed to improve the solubility and delivery of poorly water-soluble drugs, potentially transforming drug administration. Despite its promise, the technology faced hurdles, including scalability and safety concerns, leading to delays in clinical applications. These challenges affected public perception and investment in medical innovations, hindering advancements in drug delivery systems during that period.